Ljubicic Neven
Division of Digestive Diseases, Endoscopy Unit, Department of Internal Medicine, "Sestre milosrdnice" Clinical Hospital, Zagreb, Croatia.
Hepatogastroenterology. 2006 Mar-Apr;53(68):224-7.
BACKGROUND/AIMS: Dieulafoy's lesion is a rare cause of upper gastrointestinal hemorrhage. The aim of this prospective study was to assess the efficacy and safety of endoscopic clipping for upper gastrointestinal bleeding due to Dieulafoy's lesion.
From January 1998 to March 2001, 21 patients (9 women and 12 men; mean age 66 +/- 16 yrs) with bleeding Dieulafoy's lesion have been admitted. Endoscopic clipping was performed in all patients using a clipping device consisting of a clip applicator device and stainless steel hemoclips (Olympus, Japan). A follow-up endoscopy was performed within the following 24-48 hours to confirm the success of hemostasis. Hemostatic rate, rebleeding rate, amount of blood transfusion, and duration of hospital stay were analyzed.
The initial hemoclip therapy was successful in 20 out of 21 (95.2%) patients. Two patients had recurrent bleeding. One patient in whom recurrent bleeding occurred died. The successful surgical treatment was done in one patient in whom initial hemoclip therapy was unsuccessful. Therefore, the overall hemostasis was observed in 19 out of 21 patients (90.5%). There were no complications related to endoscopic therapy.
Endoscopic hemoclipping provided a very effective and safe modality for hemostasis in patients with bleeding Dieulafoy's lesions.
背景/目的:Dieulafoy病是上消化道出血的罕见病因。本前瞻性研究的目的是评估内镜下夹子夹闭术治疗Dieulafoy病所致上消化道出血的疗效和安全性。
1998年1月至2001年3月,收治了21例Dieulafoy病出血患者(9例女性,12例男性;平均年龄66±16岁)。所有患者均使用由夹子施夹器和不锈钢止血夹(日本奥林巴斯)组成的夹闭装置进行内镜下夹闭术。在接下来的24 - 48小时内进行随访内镜检查以确认止血成功。分析止血率、再出血率、输血量和住院时间。
21例患者中有20例(95.2%)首次使用止血夹治疗成功。2例患者出现复发出血。1例复发出血的患者死亡。1例首次止血夹治疗失败的患者成功接受了手术治疗。因此,21例患者中有19例(90.5%)实现了总体止血。未发生与内镜治疗相关的并发症。
内镜下止血夹夹闭术为Dieulafoy病出血患者提供了一种非常有效且安全的止血方式。